The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study

This publication has 38 references indexed in Scilit:

• Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
  Nephrology Dialysis Transplantation, 2001
• The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
  Journal of the Renin-Angiotensin-Aldosterone System, 2000
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
  Kidney International, 1999
• Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy
  Diabetic Medicine, 1999
• Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic Patients
  Nephron, 1997
• Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
  Kidney International, 1996
• Diabetes in Urban African-Americans: II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes
  Diabetes Care, 1995
• Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes
  Diabetic Medicine, 1984
• Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
  New England Journal of Medicine, 1984
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958